查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948269

2026年全球性传染病诊断市场报告

STD Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，性行为感染（STI）诊断市场发展迅速，预计将从2025年的107.7亿美元成长到2026年的119.1亿美元，复合年增长率（CAGR）为10.6%。过去几年的成长可归因于性行为感染的增加、诊断检测机构的扩张、公共卫生筛检计画的扩展、性健康意识提升以及先进核酸检测技术的广泛应用。

预计未来几年，性性行为感染）诊断市场将快速成长，到2030年市场规模将达到175.2亿美元，复合年增长率（CAGR）为10.1%。预测期内的成长可归因于对快速诊断需求的增加、家用检测套组的普及、分子诊断技术的渗透率提高、公共卫生监测投入的增加以及对保密性和便捷性检测服务的日益重视。预测期内的主要趋势包括：快速和照护现场（POC​​）性行为感染检测的普及、分子诊断技术的广泛应用、自动化检测系统的整合度不断提高、家用性性行为感染检测解决方案的扩展以及对早期准确疾病检测的日益重视。

预计未来几年，性行为感染发生率的上升将推动性传染性行为感染）诊断领域的扩张。性行为感染主要透过性接触传播，需要及时进行医学检测和临床治疗。这些感染疾病的上升趋势主要归因于年轻人性行为的活性化和社会行为的改变。性健康污名化的减少和流动性的增强促进了性网络的扩张，也增加了感染风险。随着医疗机构越来越多地采用复杂的检测方法、筛检工具和先进的检测技术来进行早期发现和预防感染，这种上升趋势直接推动了对诊断解决方案的需求。例如，根据美国疾病管制与预防中心（CDC）2025年9月发布的数据，先天性梅毒病例数预计将连续第12年增加，到2024年将达到约4,000例通报病例。因此，性传染感染性行为感染传染病诊断市场的成长。

为了满足未被满足的医疗需求并提高诊断能力，性行为感染诊断市场的主要企业正致力于开发创新产品，例如即时PCR试剂盒。即时PCR试剂盒包含一组用于进行即时聚合酵素链锁反应（qPCR）的试剂，qPCR是一种高灵敏度且应用广泛的检测和定量特定核酸序列的技术。例如，2023年3月，中国研发公司江苏博奥菲斯科技有限公司推出了“霉浆菌即时PCR试剂盒”和“梅毒螺旋体即时PCR试剂盒”，分别用于检测霉浆菌和梅毒螺旋体。这些试剂盒具有高灵敏度和特异性、操作简便、快速出结果以及单次检测多种病原体的能力。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球性传染病诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 扩大快速、照护现场性行为感染检测的应用
    • 扩大分子诊断技术的应用
    • 自动化检测系统整合的进展
    • 扩大居家性性行为感染检测方案
    • 人们越来越重视疾病的早期准确检测

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 诊断中心
  • 公共卫生研究所
  • 家庭检测服务提供者

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球性传染病诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球性传染病诊断市场规模、对比及成长率分析
  • 全球性传染病诊断市场表现：规模与成长，2020-2025年
  • 全球性传染病诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 披衣菌感染检测、梅毒检测、淋病检测、单纯疱疹病毒检测、人类乳突病毒检测、人类免疫力缺乏病毒检测、软性下疳检测
  • 通过测试施行地点
  • 检查室、照护现场检测（PoC）
  • 最终用户
  • 医院、诊所、诊断中心、居家医疗
  • 按类型细分：披衣菌感染检测
  • 核酸增幅检查（NAAT）、抗原检测
  • 按类型细分：梅毒检测
  • 快速血浆反应 (RPR) 试验、密螺旋体试验
  • 按类型细分：淋病检测
  • 核酸增幅检查（NAATs）、培养检测
  • 按类型细分：单纯疱疹病毒检测
  • PCR检测、血清学检测
  • 按类型细分：人类乳突病毒检测
  • HPV DNA检测，HPV RNA检测
  • 按类型细分：人类免疫力缺乏病毒检测
  • 抗体检测、抗原或抗体检测、核酸增幅检查（NAT）
  • 按类型细分：软性下疳检查
  • 培养检测、核酸检测

第十章 区域与国家分析

  • 全球性传染病诊断市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球性传染病诊断市场：按国家/地区划分，实际值和预测值，2020-2025 年、2025-2030 年预测值、2035 年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 性传染病诊断市场：竞争格局及市场占有率（2024年）
  • 性传染病诊断市场：公司估值矩阵
  • 性传染病诊断市场：公司概况
    • Abbott Laboratories
    • Qiagen Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic Inc.

第37章：其他领先和创新企业

  • Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年性传染病诊断市场：提供新机会的国家
  • 2030年性传染病诊断市场：新兴细分市场机会
  • 2030年性传染病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MSDIA01_G26Q1

Sexually Transmitted Diseases (STDs) diagnostics encompass the examination and identification of infectious conditions transmitted through sexual contact. These diagnostic procedures are essential in determining the presence of STDs within an individual.

The primary categories of STD diagnostics include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, chancroid, and other tests performed in laboratory and point-of-care settings. Chlamydia testing involves a urine sample analysis to detect infection. This specific test is employed for identifying chlamydia infections, a common bacterial sexually transmitted infection (STI) transmitted through various forms of sexual contact or genital exposure. These STD diagnostic procedures find application in hospitals, clinics, diagnostic centers, and homecare settings.

Tariffs are influencing the std diagnostics market by increasing costs of imported reagents, assay kits, diagnostic instruments, and molecular testing components used in laboratory and point-of-care settings. Healthcare providers in North America and Europe are most affected due to reliance on imported test kits, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are raising testing prices and affecting screening program budgets. At the same time, they are supporting local reagent production, domestic diagnostic manufacturing, and regional supply chain strengthening.

The std diagnostics market research report is one of a series of new reports from The Business Research Company that provides std diagnostics market statistics, including std diagnostics industry global market size, regional shares, competitors with a std diagnostics market share, detailed std diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the std diagnostics industry. This std diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The std diagnostics market size has grown rapidly in recent years. It will grow from $10.77 billion in 2025 to $11.91 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing prevalence of sexually transmitted infections, expansion of diagnostic laboratory infrastructure, growing public health screening programs, rising awareness of sexual health, availability of advanced nucleic acid testing.

The std diagnostics market size is expected to see rapid growth in the next few years. It will grow to $17.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostics, rising adoption of home-based testing kits, expansion of molecular diagnostics penetration, growing investments in public health surveillance, increasing focus on confidential and accessible testing services. Major trends in the forecast period include increasing adoption of rapid and point-of-care std tests, rising use of molecular diagnostic technologies, growing integration of automated laboratory systems, expansion of at-home std testing solutions, enhanced focus on early and accurate disease detection.

The increasing incidence of sexually transmitted diseases is expected to drive the expansion of the STD diagnostics sector in the coming years. Sexually transmitted diseases are infections spread primarily through sexual contact and require timely medical testing and clinical management. The rising burden of these infections is largely attributed to higher levels of sexual activity and evolving social behaviors among younger populations, where reduced stigma around sexual health and increased mobility have contributed to broader sexual networks and elevated transmission risks. This growing prevalence directly fuels demand for diagnostic solutions, as healthcare providers increasingly rely on precise laboratory assays, screening tools, and advanced detection technologies to identify infections early and limit further spread. For example, in September 2025, data from the Centers for Disease Control and Prevention indicated that cases of congenital syphilis increased for the twelfth consecutive year, reaching nearly 4,000 reported cases in 2024. As a result, the rising prevalence of sexually transmitted diseases is contributing significantly to the growth of STD diagnostics.

Key companies in the STD diagnostics market are focusing on developing innovative products, such as real-time PCR kits, to meet unmet medical needs and improve diagnostic capabilities. A real-time PCR kit consists of a collection of reagents utilized for conducting real-time polymerase chain reaction (qPCR), a sensitive and commonly employed technique for detecting and quantifying specific nucleic acid sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, introduced the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, specifically designed for detecting Mycoplasma hominis and Treponema pallidum. These kits offer high sensitivity and specificity, user-friendliness, rapid turnaround times, and the capability to detect multiple pathogens in a single test.

In February 2024, Thyrocare, an India-based healthcare company, acquired Think Health Care for an undisclosed amount. With this acquisition, Thyrocare aims to strategically enhance its service offerings and market reach, especially in the home healthcare segment. Think Health Care is an India-based company specializing in diagnostic and preventive healthcare, known for providing at-home ECG services.

Major companies operating in the std diagnostics market are Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

North America was the largest region in the STD diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the std diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers - immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

STD Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses std diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for std diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The std diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Chlamydia Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus Testing; Human Papilloma Virus Testing; Human Immunodeficiency Virus Testing; Chancroid Testing
  • 2) By Location Of Testing: Laboratory Testing; Point Of Care (PoC) Testing
  • 3) By End-User: Hospitals And Clinics; Diagnostic Centers; Homecare
  • Subsegments:
  • 1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT); Antigen Tests
  • 2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests; Treponemal Tests
  • 3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT); Culture Tests
  • 4) By Herpes Simplex Virus Testing: PCR Tests; Serological Tests
  • 5) By Human Papilloma Virus Testing: HPV DNA Tests; HPV RNA Tests
  • 6) By Human Immunodeficiency Virus Testing: Antibody Tests; Antigen Or Antibody Tests; Nucleic Acid Tests (NAT)
  • 7) By Chancroid Testing: Culture Tests; Nucleic Acid Tests
  • Companies Mentioned: Abbott Laboratories; Qiagen Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; Hologic Inc.; Bio-Rad Laboratories Inc.; Becton Dickinson and Company; Thermo Fisher Scientific Inc.; Biocartis NV; Trinity Biotech PLC; Binx Health Inc.; NOWDiagnostics Inc.; Atlas Genetics Ltd.; BioFire Diagnostics LLC; BioMerieux SA; Chembio Diagnostic Systems Inc.; Corgenix Medical Corporation; Creative Diagnostics; Curetis AG; Daktari Diagnostics; Enzo Biochem Inc.; Fujirebio Diagnostics Inc.; GenePOC Inc.; GenMark Diagnostics Inc.; Grifols Diagnostic Solutions Inc.; Hain Lifescience GmbH; Luminex Corporation; Meridian Bioscience Inc.; Mesa Biotech Inc.; Mobidiag Oy
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. STD Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global STD Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. STD Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global STD Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Rapid And Point-Of-Care Std Tests
    • 4.2.2 Rising Use Of Molecular Diagnostic Technologies
    • 4.2.3 Growing Integration Of Automated Laboratory Systems
    • 4.2.4 Expansion Of At-Home Std Testing Solutions
    • 4.2.5 Enhanced Focus On Early And Accurate Disease Detection

5. STD Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Diagnostic Centers
  • 5.4 Public Health Laboratories
  • 5.5 Homecare Testing Providers

6. STD Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global STD Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global STD Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global STD Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global STD Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global STD Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global STD Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. STD Diagnostics Market Segmentation

  • 9.1. Global STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing
  • 9.2. Global STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Testing, Point Of Care (PoC) Testing
  • 9.3. Global STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Centers, Homecare
  • 9.4. Global STD Diagnostics Market, Sub-Segmentation Of Chlamydia Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nucleic Acid Amplification Tests (NAAT), Antigen Tests
  • 9.5. Global STD Diagnostics Market, Sub-Segmentation Of Syphilis Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rapid Plasma Reagin (RPR) Tests, Treponemal Tests
  • 9.6. Global STD Diagnostics Market, Sub-Segmentation Of Gonorrhea Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nucleic Acid Amplification Tests (NAAT), Culture Tests
  • 9.7. Global STD Diagnostics Market, Sub-Segmentation Of Herpes Simplex Virus Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PCR Tests, Serological Tests
  • 9.8. Global STD Diagnostics Market, Sub-Segmentation Of Human Papilloma Virus Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • HPV DNA Tests, HPV RNA Tests
  • 9.9. Global STD Diagnostics Market, Sub-Segmentation Of Human Immunodeficiency Virus Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)
  • 9.10. Global STD Diagnostics Market, Sub-Segmentation Of Chancroid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Culture Tests, Nucleic Acid Tests

10. STD Diagnostics Market Regional And Country Analysis

  • 10.1. Global STD Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global STD Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific STD Diagnostics Market

  • 11.1. Asia-Pacific STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China STD Diagnostics Market

  • 12.1. China STD Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India STD Diagnostics Market

  • 13.1. India STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan STD Diagnostics Market

  • 14.1. Japan STD Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia STD Diagnostics Market

  • 15.1. Australia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia STD Diagnostics Market

  • 16.1. Indonesia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea STD Diagnostics Market

  • 17.1. South Korea STD Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan STD Diagnostics Market

  • 18.1. Taiwan STD Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia STD Diagnostics Market

  • 19.1. South East Asia STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe STD Diagnostics Market

  • 20.1. Western Europe STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK STD Diagnostics Market

  • 21.1. UK STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany STD Diagnostics Market

  • 22.1. Germany STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France STD Diagnostics Market

  • 23.1. France STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy STD Diagnostics Market

  • 24.1. Italy STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain STD Diagnostics Market

  • 25.1. Spain STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe STD Diagnostics Market

  • 26.1. Eastern Europe STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia STD Diagnostics Market

  • 27.1. Russia STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America STD Diagnostics Market

  • 28.1. North America STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA STD Diagnostics Market

  • 29.1. USA STD Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada STD Diagnostics Market

  • 30.1. Canada STD Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America STD Diagnostics Market

  • 31.1. South America STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil STD Diagnostics Market

  • 32.1. Brazil STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East STD Diagnostics Market

  • 33.1. Middle East STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa STD Diagnostics Market

  • 34.1. Africa STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa STD Diagnostics Market, Segmentation By Type, Segmentation By Location Of Testing, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. STD Diagnostics Market Regulatory and Investment Landscape

36. STD Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. STD Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. STD Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. STD Diagnostics Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Qiagen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

37. STD Diagnostics Market Other Major And Innovative Companies

  • Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics

38. Global STD Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The STD Diagnostics Market

40. STD Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 STD Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 STD Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 STD Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer